Analyst price target range
ImmunityBio Price Target: $12.75 Average
Direct answer
ImmunityBio's average price target is $12.75.
The verified analyst range runs from $12.00 to $15.00.
The low target implies +48.5%, the high target implies +85.6%, and the range spans 37.1% of the current price.
Forecast evidence checked September 6, 2026.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.08
- Average price target
- $12.75
- High price target
- $15.00
- Low price target
- $12.00
- Low target gap
- +48.5%
- Target upside
- +57.8%
- High target gap
- +85.6%
- Target range width
- 37.1%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- September 6, 2026
- Valid through
- September 13, 2026
Explore related company data
Read the frequently asked questions.
What is ImmunityBio's average price target?
ImmunityBio's verified average price target is $12.75. The target range is $12.00 to $15.00.
How far are ImmunityBio's low and high targets from the recorded price?
The low target implies +48.5%, while the high target implies +85.6%.
How many analysts are included in ImmunityBio's consensus?
The verified consensus includes 4 analysts.
How is ImmunityBio's target upside or downside calculated?
The average target of $12.75 is divided by the recorded price of $8.08, then one is subtracted to produce +57.8%. This does not guarantee a future return.
When was ImmunityBio's analyst forecast verified?
The data was verified on 2026-09-06. The dataset is valid through 2026-09-13.